Schonfeld Strategic Advisors’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
MAM
WC
FCM
LG
MCM
AI
IC
Schonfeld Strategic Advisors's STIM Position: Q2 2026 in Review
Schonfeld Strategic Advisors sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 31,751 shares — an estimated $46K sold.
Schonfeld Strategic Advisors first reported a position in STIM in Q4 2022 and held it in 3 quarters. The position peaked at $96.2K in Q4 2022. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.
- Schonfeld Strategic Advisors reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
- Schonfeld Strategic Advisors sold 31,751 Neuronetics shares in Q2 2026, an estimated $46K.
- Schonfeld Strategic Advisors first reported a position in Neuronetics in Q4 2022 and held it in 3 quarters.
- Schonfeld Strategic Advisors's Neuronetics position peaked at $96.2K in Q4 2022.
- 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.